Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Clascoterone vs Salicylic Acid (topical): they're closely matched on evidence (7 vs 5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Clascoterone and Salicylic Acid (topical) are closely matched across evidence, studies, and safety.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Clascoterone and Salicylic Acid (topical) have evidence — compare verdict strength side-by-side.
Apply a thin layer of clascoterone 1% cream to the affected area twice daily, morning and evening, on clean dry skin
Morning and evening
Clascoterone 1% cream
Topical OTC use. Leave-on and wash-off acne products contain 0.5-2% salicylic acid, applied to affected areas once or twice daily and built up as tolerated; professional peels (20-30%) are applied in-office. There is no oral or systemic dose in this context — it is not ingested (and large-area/high-concentration use can cause systemic salicylate absorption, so follow label limits). This library does not provide an ingestion protocol.
any
Leave-on or wash-off acne product (0.5-2% salicylic acid)
immediate
12 weeks
12 weeks
1-4 weeks
Throughout
4-12 weeks
4-12 weeks
Throughout
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials
JAMA Dermatol (2020) · Rct · n=1440
The pivotal registration trials: two identical phase 3 studies, 1440 patients randomised, conducted November 2015 to April 2018.
Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris
J Drugs Dermatol (2023) · Rct · n=1421
709 patients received clascoterone and 712 received vehicle in the pooled ≥12-year population.
Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials
Dermatol Ther (2021) · Meta analysis · n=2457
Five trials, 2457 patients (1357 clascoterone, 1100 placebo), overall low risk of bias.
Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris.
Dermatol Surg (2008) · Rct · n=20
Split-face, double-blind RCT (n=20) comparing 30% salicylic acid vs 30% glycolic acid peels, six treatments at 2-week intervals
Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study.
Drugs Exp Clin Res (2003) · Rct · n=37
12-week double-blind RCT (n=37) comparing a 2% salicylic acid (plus chloroxylenol) cream vs benzoyl peroxide 5% gel twice daily
Comparative study of efficacy and safety of 45% mandelic acid versus 30% salicylic acid peels in mild-to-moderate acne vulgaris.
J Cosmet Dermatol (2020) · Rct · n=50
Randomized trial (n=50) of 30% salicylic acid vs 45% mandelic acid peels, six sessions over 12 weeks for mild-to-moderate acne
Both Clascoterone and Salicylic Acid (topical) are closely matched — the best choice depends on your specific health goals.
For clearer skin (acne), Clascoterone has a higher relevance score (92 vs 75).
No known interactions between Clascoterone and Salicylic Acid (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.